APA

Adar T., Faleck D., Sasidharan S., Cushing K., Borren N. Z., Nalagatla N., Ungaro R., Sy W., Owen S. C., Patel A., Cohen B. L. & Ananthakrishnan A. N. (20200323). Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study. : Alimentary pharmacology & therapeutics.

Chicago

Adar Tomer, Faleck David, Sasidharan Saranya, Cushing Kelly, Borren Nienke Z, Nalagatla Niharika, Ungaro Ryan, Sy Wayne, Owen Samuel C, Patel Anish, Cohen Benjamin L and Ananthakrishnan Ashwin N. 20200323. Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study. : Alimentary pharmacology & therapeutics.

Harvard

Adar T., Faleck D., Sasidharan S., Cushing K., Borren N. Z., Nalagatla N., Ungaro R., Sy W., Owen S. C., Patel A., Cohen B. L. and Ananthakrishnan A. N. (20200323). Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study. : Alimentary pharmacology & therapeutics.

MLA

Adar Tomer, Faleck David, Sasidharan Saranya, Cushing Kelly, Borren Nienke Z, Nalagatla Niharika, Ungaro Ryan, Sy Wayne, Owen Samuel C, Patel Anish, Cohen Benjamin L and Ananthakrishnan Ashwin N. Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study. : Alimentary pharmacology & therapeutics. 20200323.